These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3473646)

  • 41. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K
    Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
    van Blokland SC; Versnel MA
    Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
    Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
    Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pulse therapy in the complex treatment of severe forms of Sjögren's syndrome and disease].
    Vasil'ev VI; Solov'ev SK; Simonova MV; Safonova TN; Nasonov EL
    Ter Arkh; 1986; 58(7):117-22. PubMed ID: 3764727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sulfasalazine therapy for hypergammaglobulinemia in patients with Sjögren's syndrome].
    Imai F; Suzuki T; Ishibashi T; Ohno S; Tanaka M; Dohi Y
    Arerugi; 1994 Jan; 43(1):68-70. PubMed ID: 7908513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
    Ohashi Y; So SK; Minasi PN; Tabbara KF
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glomerulonephritis in Sjögren's syndrome (case report)].
    Lopatkina TN; Nikolaev AIu; Khasabov NN; Varshavskiĭ VA; Kuprianova LA
    Ter Arkh; 1980; 52(4):124-5. PubMed ID: 6447373
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis.
    Gunn HC; Ryffel B
    Clin Exp Immunol; 1986 May; 64(2):234-42. PubMed ID: 3742874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sjogren's syndrome. When your tissues dry out.
    Mayo Clin Health Lett; 2006 Jul; 24(7):7. PubMed ID: 16865802
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sjögren's syndrome].
    Okada J; Kondo H
    Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):384-7. PubMed ID: 9277945
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum isoamylases in Sjögren's syndrome. Concentration levels and intra-individual variation.
    Magid E; Frost-Larsen K; Isager H; Manthorpe R; Prause JU
    Scand J Rheumatol; 1983; 12(2):129-32. PubMed ID: 6190225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sicca syndrome associated with idiopathic haemochromatosis.
    Blandford RL; Dowdle JR; Stephens MR; Walker DM
    Br Med J; 1979 May; 1(6174):1323. PubMed ID: 445052
    [No Abstract]   [Full Text] [Related]  

  • 55. Lack of lacrimal gland improvement by NA-872 in Sjögren's syndrome.
    Manthorpe R; Frost-Larsen K; Isager H; Prause JU
    Acta Ophthalmol (Copenh); 1981 Jun; 59(3):428-9. PubMed ID: 7034455
    [No Abstract]   [Full Text] [Related]  

  • 56. Mucosolvan in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigation.
    Manthorpe R; Petersen SH; Prause JU
    Acta Ophthalmol (Copenh); 1984 Aug; 62(4):537-41. PubMed ID: 6385607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of low dietary lipid on the development of Sjögren's syndrome and haematological abnormalities in (NZB x NZW)F1 mice.
    Swanson CA; Levy JA; Morrow WJ
    Ann Rheum Dis; 1989 Sep; 48(9):765-70. PubMed ID: 2802799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glomerulonephritis in NZW kidneys grafted into NZB/W mice.
    Inoue K; Niesen N; Milgrom F; Albini B
    Int Arch Allergy Appl Immunol; 1991; 96(4):355-7. PubMed ID: 1809692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bromhexine has no effect].
    Cronberg S; Melander A; Stenberg P
    Lakartidningen; 1978 Mar; 75(10):920-2. PubMed ID: 342840
    [No Abstract]   [Full Text] [Related]  

  • 60. [Documentation on bromhexine: What is the truth?].
    Mossberg B; Nilsson BS
    Lakartidningen; 1978 Mar; 75(9):765-7. PubMed ID: 628271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.